ArticleCancer research communications2025

Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR- and KRAS-Mutant Lung Cancer.

Xiaoxiao Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.